The Global Iohexol Market was valued at approximately USD 780 Million in 2024 and is projected to reach over USD 1.1 Billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of around 5.8% during the forecast period (2024–2030). This robust growth is primarily driven by the rising global incidence of chronic diseases requiring diagnostic imaging, advancements in medical technology, and expanding healthcare infrastructure in emerging economies.

As the demand for clear and safe diagnostic procedures escalates, the focus intensifies on the pharmaceutical companies that manufacture high-purity contrast agents. In this analysis, we profile the Top 10 Companies in the Iohexol Industry—a group of established pharmaceutical giants and specialized manufacturers ensuring the supply of this critical medical ingredient worldwide.

Download FREE Sample Report:
Iohexol Market – View in Detailed Research Report

---

🔟 1. GE Healthcare

Headquarters: Chicago, Illinois, USA
Key Offering: Omnipaque (Iohexol) Injection

GE Healthcare is a global leader in medical imaging and diagnostics, and its Omnipaque brand is one of the most widely recognized non-ionic contrast media products worldwide. The company provides Iohexol-based solutions for computed tomography (CT), angiography, and other radiographic procedures.

Innovation and Market Focus:

• Continuous investment in R&D for improved safety profiles

• Strong global distribution network for hospital and clinical access

• Focus on patient-centric formulations to minimize adverse effects

---

9️⃣ 2. LGC Group

Headquarters: Teddington, United Kingdom
Key Offering: High-Purity Iohexol Reference Standards

While not a therapeutic manufacturer, LGC Group plays a crucial role as a leading global life science tools company. It supplies high-purity Iohexol chemical reference standards essential for quality control, research, and regulatory compliance for pharmaceutical manufacturers worldwide.

Innovation and Market Focus:

• Provision of certified reference materials (CRMs) for accurate assay

• Supporting pharmaceutical quality and safety through rigorous standards

---

8️⃣ 3. Zhejiang Hisun Pharmaceutical

Headquarters: Taizhou, Zhejiang, China
Key Offering: Iohexol API and Formulations

Zhejiang Hisun Pharmaceutical is a major Chinese pharmaceutical company with a significant presence in the active pharmaceutical ingredient (API) market. It is a key supplier of Iohexol, catering to both domestic and international markets with competitive manufacturing capabilities.

Innovation and Market Focus:

• Expansion of API production capacity to meet growing demand

• Strategic focus on cost-effective manufacturing processes

---

7️⃣ 4. Zhejiang Starry Pharmaceutical Co., Ltd.

Headquarters: Taizhou, Zhejiang, China
Key Offering: Iohexol API

Zhejiang Starry Pharmaceutical specializes in the research, development, and production of APIs, including Iohexol. The company has established itself as a reliable manufacturer in the global contrast media supply chain.

Innovation and Market Focus:

• Investment in advanced synthesis and purification technologies

• Compliance with international regulatory standards (e.g., FDA, EMA)

Download FREE Sample Report:
Iohexol Market – View in Detailed Research Report

---

6️⃣ 5. Interpharma Praha a.s.

Headquarters: Prague, Czech Republic
Key Offering: Iohexol and other contrast media APIs

Interpharma Praha is a European pharmaceutical company with expertise in developing and producing APIs for contrast media. It serves as an important supplier to the European pharmaceutical market, emphasizing quality and regulatory adherence.

Innovation and Market Focus:

• Strong foothold in the European Economic Area

• Focus on niche and specialized pharmaceutical ingredients

---

5️⃣ 6. Zhejiang Hichi Pharmaceutical Co., Ltd.

Headquarters: Taizhou, Zhejiang, China
Key Offering: Iohexol API

Zhejiang Hichi Pharmaceutical is another key Chinese player focused on the production of Iohexol API. The company contributes significantly to the global supply, leveraging its manufacturing scale and expertise in chemical synthesis.

Innovation and Market Focus:

• Optimization of production yields and efficiency

• Building long-term partnerships with global formulation companies

---

4️⃣ 7. Shanghai Shucan Biotechnology Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Iohexol and diagnostic chemical intermediates

Shanghai Shucan operates in the biotechnology and fine chemical sectors, supplying Iohexol and related compounds. The company supports the diagnostic imaging industry with high-quality chemical inputs.

Innovation and Market Focus:

• Integration of biotechnology in chemical production processes

• Catering to a diverse client base in the healthcare sector

---

3️⃣ 8. Beijing Beilu Pharmaceutical Co., Ltd.

Headquarters: Beijing, China
Key Offering: Iohexol formulations and APIs

Beijing Beilu Pharmaceutical is a significant domestic manufacturer in China’s pharmaceutical landscape. The company produces Iohexol for the Chinese market, which is one of the fastest-growing regions for medical diagnostics.

Innovation and Market Focus:

• Alignment with China’s growing healthcare and medical imaging needs

• Focus on accessibility and affordability of contrast media

---

2️⃣ 9. Other Established API Manufacturers

Headquarters: Global
Key Offering: Iohexol API Supply

Beyond the top branded and specialized manufacturers, a segment of the market consists of other established chemical and pharmaceutical companies that produce Iohexol API. These players often supply the generic pharmaceutical market and regional distributors, contributing to market volume and competitive pricing.

Market Role:

• Ensuring supply chain resilience through multiple sources

• Driving cost competitiveness in the generic segment

---

1️⃣ 10. Regional Formulation and Distribution Specialists

Headquarters: Various regions globally
Key Offering: Branded and Generic Iohexol Injections

This category includes numerous pharmaceutical companies that may not manufacture the API but are crucial in formulating, branding, and distributing the final Iohexol injection product within specific geographic regions. They play a vital role in the last-mile delivery of contrast media to hospitals and clinics.

Market Role:

• Local regulatory management and market authorization

• Building strong relationships with healthcare providers

Get Full Report Here:
Iohexol Market – View in Detailed Research Report

---

🌍 Outlook: Precision Diagnostics Fueling Iohexol Market Evolution

The Iohexol market is on a steady growth trajectory, underpinned by irreversible global healthcare trends. While established products dominate current sales, the industry is witnessing a strategic shift towards enhanced safety profiles, supply chain robustness, and geographic expansion to untapped markets.

📈 Key Trends Shaping the Market:

• Increasing preference for non-ionic, low-osmolar contrast agents like Iohexol over older alternatives

• Rising geriatric population and subsequent increase in diagnostic imaging procedures

• Technological advancements in CT and MRI scanning, requiring high-quality contrast media

• Growing healthcare expenditure and insurance coverage in emerging economies

Get Full Report Here:
Iohexol Market – View in Detailed Research Report

The companies profiled above are not merely suppliers; they are enablers of modern diagnostics, ensuring that healthcare professionals worldwide have access to the reliable contrast media needed for accurate disease detection and patient care.